These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
527 related items for PubMed ID: 7572237
1. Prostacyclin aerosol and inhaled nitric oxide fail to reverse pulmonary vasoconstriction induced by thromboxane analogue in dogs. Welte M, Zwissler B, Habler O, Kleen M, Messmer K. Acta Physiol Scand; 1995 Jul; 154(3):395-405. PubMed ID: 7572237 [Abstract] [Full Text] [Related]
2. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension. Walmrath D, Schermuly R, Pilch J, Grimminger F, Seeger W. Eur Respir J; 1997 May; 10(5):1084-92. PubMed ID: 9163651 [Abstract] [Full Text] [Related]
4. Site of pulmonary vasodilation by inhaled nitric oxide in the perfused lung. Rimar S, Gillis CN. J Appl Physiol (1985); 1995 May; 78(5):1745-9. PubMed ID: 7649908 [Abstract] [Full Text] [Related]
5. Effects of inhaled prostacyclin as compared with inhaled nitric oxide in a canine model of pulmonary microembolism and oleic acid edema. Zwissler B, Welte M, Habler O, Kleen M, Messmer K. J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):634-40. PubMed ID: 8664452 [Abstract] [Full Text] [Related]
6. Vasoconstriction increases pulmonary nitric oxide synthesis and circulating cyclic GMP. Wilson PS, Thompson WJ, Moore TM, Khimenko PL, Taylor AE. J Surg Res; 1997 Jun; 70(1):75-83. PubMed ID: 9228932 [Abstract] [Full Text] [Related]
7. Efficacy of inhaled prostanoids in experimental pulmonary hypertension. Kleen M, Habler O, Hofstetter C, Pusch R, Mueller M, Welte M, Zwissler B. Crit Care Med; 1998 Jun; 26(6):1103-9. PubMed ID: 9635662 [Abstract] [Full Text] [Related]